HOME >> MEDICINE >> NEWS
SNM collaboration yields diagnostic nuclear medicine guide for compliance with NRC regulations

Reston, VA....The Society of Nuclear Medicine (SNM) announced today the release of a unique, one-stop reference work for diagnostic nuclear medicine professionals who want to bring their departments and institutions into compliance with recently revised federal regulations governing the medical use of byproduct material. Guide for Diagnostic Nuclear Medicine, published by the SNM and authored by Jeffry A. Siegel, PhD, represents the first major joint effort between the Nuclear Regulatory Commission (NRC; Bethesda, MD) and a stakeholder organization whose members' professional practices are regulated by NRC rules.

The new NRC regulations under 10 CFR Part 35 (Medical Use of Byproduct Material) became effective October 24, 2002, and govern the medical use and licensing of byproduct materials across the spectrum of diagnostic practice. The revised rule is intended to be less prescriptive than the current rule. The most significant change, according to Siegel, is "a new emphasis on risk-informed, performance-based approaches that focus not on procedures but on outcomes." Since the first use of nuclear medicine in the United States in the 1940s, more than one-third of a billion doses have been administered to patients, with unparalleled safety and almost no adverse events. In structuring the new regulations, the NRC took this low risk into account by eliminating or decreasing the prescriptiveness of the regulations that apply to diagnostic nuclear medicine. Instead, the NRC is relying on a performance-based approach that emphasizes not a step-by-step adherence to "best practices" but a consistent level of performance outcomes by institutions at which nuclear medicine is practiced.

"With this changed focus, we knew that it would be useful for practitioners to have a stand-alone document that suggests appropriate operating policies and sample procedures for compliance with the revised Part 35 and with other NRC regulations," says Siegel, who is chair of t
'"/>

Contact: Becky Haines
Bhaines@snm.org
703-708-9000
Society of Nuclear Medicine
30-Oct-2002


Page: 1 2 3

Related medicine news :

1. Houston meeting kicks off collaboration to advance cancer research
2. Novartis announces collaboration with Bayer for EMSELEX
3. Call for national collaboration on medical education research
4. Former President George Bush joins leaders from cancer community to announce historic collaboration
5. University of Pittsburgh and French National Institute begin scientific collaboration
6. Nordic collaboration gives new insights into adjuvant chemotherapy
7. UCSD-TCAG collaboration to focus on transformation of genome-based knowledge into health benefits
8. $15 million grant spurs cancer collaboration; M. D. Anderson, University of Puerto Rico
9. UNC Center for AIDS Research database collaboration with SAS also helping patient care
10. NIH-funded UCSD rheumatic diseases center to facilitate collaboration, speed discoveries
11. New rapid anthrax test developed through collaboration between Mayo Clinic and Roche Diagnostics. Test, which provides results in less than one hour, will be made available to United States laboratories

Post Your Comments:
(Date:10/20/2014)... 2014 Allegheny General Hospital’s (AGH) Cardiovascular ... physicians to repair a damaged mitral valve as the ... system, developed by Abbott Vascular , is designed ... life-threatening condition in which the heart’s mitral valve leaflets ... from the heart’s left ventricle into the left atrium. ...
(Date:10/20/2014)... IN (PRWEB) October 20, 2014 ... Start, a secure cloud solution that enables healthcare ... of the ultimate healthcare-specific customer relationship management (“CRM”) ... meet the unique needs of the healthcare industry, ... experience for providers and patients by combining healthcare ...
(Date:10/20/2014)... 2014 AttorneyOne.com, a recognized authority on law, ... the FDA on Sit and Slim II . ... purchase or use Sit and Slim II because it contains ... promoted as weight loss product on various websites and possibly ... in 2010 for safety reasons, can significantly increase blood pressure ...
(Date:10/20/2014)... National Teen Driver Safety Week is October 19-25, 2014 and ... AAP, http://www.ohioaap.org ) is joining the National Highway Traffic ... talk to their teens and always set the rules before ... leading cause of death for U.S. teens. In 2012, there ... (42%) of those teen drivers were killed in crashes. While ...
(Date:10/20/2014)... 20, 2014 Houston plastic surgeon ... key elements of his innovative True Form Tummy ... surgery residents and faculty at The University of ... too, was once a medical student. Patronella, who is ... cosmetic plastic surgery practices in Texas, The Aesthetic ...
Breaking Medicine News(10 mins):Health News:Allegheny General Hospital Introduces New, Beating-Heart Procedure for Mitral Valve Repair 2Health News:Allegheny General Hospital Introduces New, Beating-Heart Procedure for Mitral Valve Repair 3Health News:Healthcare Relationship Management (HRM) Leader hc1.com® Launches hc1® Quick Start™ 2Health News:FDA Advises Not to Use Sit and Slim II: AttorneyOne Monitors and Keeps Consumers Informed 2Health News:Ohio AAP Promotes National Teen Driver Safety Week 2Health News:Plastic Surgeon Patronella Presents Artistically-Inspired Tummy Tuck Method to Future Generation of Plastic Surgeons in Texas 2
(Date:10/17/2014)... , October 17, 2014 Investor-Edge ... Inc. (NASDAQ: ARNA ), NPS Pharmaceuticals Inc. ... XOMA ), Momenta Pharmaceuticals Inc. (NASDAQ: ... Free research on these five companies can be accessed ... on Thursday, October 16, 2014, ended on a mixed ...
(Date:10/17/2014)... 17, 2014  UBM Medica US announces that ... and other clinicians who treat patients with type ... effective use of insulin .  Nearly ... replacement therapy – daily injections of one or ... in the function of pancreatic beta cells. Insulin is ...
(Date:10/17/2014)... -- China Biologic Products, Inc. (NASDAQ: CBPO, "China Biologic" ... biopharmaceutical company in China , ... from the China Food and Drug Administration (the ... concentrate ("PCC") at its Shandong Taibang facility. The ... facility for Good Manufacturing Practices ("GMP") compliance in ...
Breaking Medicine Technology:Biotech Equities Technical Briefing - Arena Pharma, NPS Pharma, XOMA, Momenta Pharma, and Catalyst Pharma Partners 2Biotech Equities Technical Briefing - Arena Pharma, NPS Pharma, XOMA, Momenta Pharma, and Catalyst Pharma Partners 3Biotech Equities Technical Briefing - Arena Pharma, NPS Pharma, XOMA, Momenta Pharma, and Catalyst Pharma Partners 4Biotech Equities Technical Briefing - Arena Pharma, NPS Pharma, XOMA, Momenta Pharma, and Catalyst Pharma Partners 5Endocrinology Network Features Special Coverage on Effective Use of Insulin 2Endocrinology Network Features Special Coverage on Effective Use of Insulin 3China Biologic Receives Approval for Commercial Manufacturing of Human Prothrombin Complex Concentrate at Shandong Taibang Facility 2China Biologic Receives Approval for Commercial Manufacturing of Human Prothrombin Complex Concentrate at Shandong Taibang Facility 3
Cached News: